Early-stage medtech ventures in New England now have an accelerator catered exclusively to them: MagpieX, a Providence-based program that just launched in partnership with the New England Medical Innovation Center (NEMIC).
MagpieX will provide pre-seed capital investment, along with clinical and regulatory expertise through NEMIC’s extensive network. Rather than bringing in cohorts of startups, the accelerator is accepting applications on a constantly rolling basis, with the goal of accelerating about 10 companies per year. The program itself is three months long, with the promise of continued support after graduation.
